Should the U.S. Prohibit Reproductive Cloning?
By Tim Sandle,
Digital Journal
| 04. 18. 2014
[Quotes CGS's Marcy Darnovsky]
Untitled Document
Researchers have produced stem cell lines using somatic cell nuclear transfer (SCNT) from cells, making human reproductive cloning more technically feasible. Is this a good idea?
Not according to Marcy Darnovsky, PhD, executive director of the Center for Genetics and Society, a public interest organization based in Berkeley, California.
Talking to the Digital Journal, Darnovsky said: "No one wants to wake up to headlines that a rogue fertility doctor or scientist initiated a pregnancy with a cloned human embryo."
The Center for Genetics and Society (CGS) is a non-profit public affairs and policy advocacy organization working to encourage responsible uses and effective societal governance of human genetic and reproductive biotechnologies.
The basis of Darnovsky's concern relates to a study
published in the journal
Cell Stem Cell. In the journal, researchers report that they have produced stem cell lines using somatic cell nuclear transfer (SCNT) from cells taken from two adult men. The aim of this work is to produce patient-specific stem cells for medical treatments. But unlike induced pluripotent stem cells, which can also be patient-specific, SCNT...
Related Articles
By [cites CGS' Katie Hasson], KCBS Radio | 11.19.2025
This is Ask An Expert, where every weekday at 9:20am, KCBS Radio is giving you direct access to top experts in various fields. Today: Gene-editing technology allows scientists to work with DNA in unprecedented ways, but there are larger scientific...
By Alice Miranda Ollstein and Megan Messerly, Politico | 10.25.2025
By Ben Foldy, The Wall Street Journal | 10.21.2025
AnnaMaria Gallozzi and her husband wanted to have a second child last year. Because Gallozzi has advanced breast cancer, the couple sought out a surrogate who could carry their baby.
They used crowdfunding and took out a second mortgage on...
By Megan Molteni and Anil Oza, STAT | 10.07.2025
For two years, a panel of scientific experts, clinicians, and patient advocates had been hammering out ways to increase community engagement in National Institutes of Health-funded science. When they presented their road map to the NIH Director Jay Bhattacharya last...